DrugPatentWatch Database Preview

DOXAPRAM HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Doxapram Hydrochloride patents expire, and what generic alternatives are available?

Doxapram Hydrochloride is a drug marketed by Athenex Inc and Watson Labs and is included in two NDAs.

The generic ingredient in DOXAPRAM HYDROCHLORIDE is doxapram hydrochloride. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the doxapram hydrochloride profile page.

Summary for DOXAPRAM HYDROCHLORIDE

US Patents:	0
Applicants:	2
NDAs:	2
Bulk Api Vendors:	32
Clinical Trials:	7
Patent Applications:	158
Formulation / Manufacturing:	see details
Drug Prices:	see details
DailyMed Link:	DOXAPRAM HYDROCHLORIDE at DailyMed

Medical Subject Heading (MeSH) Categories for DOXAPRAM HYDROCHLORIDE

Central Nervous System Stimulants

Respiratory System Agents

Synonyms for DOXAPRAM HYDROCHLORIDE

(+-)-1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone monohydrochloride monohydrate

081D530

1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one hydrochloride

1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone hydrochloride hydrate

1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone monohydrochloride monohydrate

1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenylpyrrolidin-2-one monohydrochloride

1-ethyl-4-(2-morpholinoethyl)-3,3-diphenylpyrrolidin-2-onemonohydrochloride

113-07-5

113D075

2-Pyrrolidinone, 1-ethyl-4-(2-(4-morpholinyl)ethyl)-3,3-diphenyl-, monohydrochloride

2-Pyrrolidinone, 1-ethyl-4-(2-(4-morpholinyl)ethyl)-3,3-diphenyl-, monohydrochloride, monohydrate

2-Pyrrolidinone, 1-ethyl-4-(2-(4-morpholinyl)ethyl)-3,3-diphenyl-, monohydrochloride, monohydrate, (+-)-

2-Pyrrolidinone, 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-, monohydrochloride

2-Pyrrolidinone, 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-, monohydrochloride, monohydrate

2-Pyrrolidinone,3-diphenyl-, monohydrochloride

3,3-Diphenyl-1-ethyl-4-(2-morpholinoethyl)-2-pyrrolidinone hydrochloride

AC-4694

AC1L21NE

AHR 619

AHR-619

AK-55670

AKOS015906444

AOB5785

API0002485

AS-13336

Bio-0166

C24H30N2O2

C24H30N2O2.HCl

CAS-113-07-5

CCG-101076

CCG-221205

CHEBI:59837

CHEMBL1200876

CPD000469229

CTK8F9367

Doxapram HCL

Doxapram hydrochloride [USAN:JAN]

Doxapram hydrochloride anhydrous

DSSTox_CID_27815

DSSTox_GSID_47837

DSSTox_RID_82579

DTXSID9047837

EINECS 204-022-3

FC1271

H927

J-002892

K-0985

LS-138812

MBGXILHMHYLZJT-UHFFFAOYSA-N

MCULE-1905124271

MFCD00072148

MLS001424142

MolPort-005-973-141

NC00326

NCGC00167459-01

NCGC00167459-02

NSC-170958

NSC170958

SAM001246792

SCHEMBL40645

SMR000469229

Stimulexin

Tox21_112463

Tox21_112463_1

US Patents and Regulatory Information for DOXAPRAM HYDROCHLORIDE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Athenex Inc	DOXAPRAM HYDROCHLORIDE	doxapram hydrochloride	INJECTABLE;INJECTION	076266-001	Jan 10, 2003	AP	RX	No	No
Watson Labs	DOXAPRAM HYDROCHLORIDE	doxapram hydrochloride	INJECTABLE;INJECTION	073529-001	Jan 30, 1992		DISCN	No	No